444 related articles for article (PubMed ID: 12461063)
21. The Role of P63 Immunocytochemistry for Myoepithelial Cells in the Diagnosis of Atypical and Suspicious Cases in Breast Fine Needle Aspiration Cytology (FNAC).
Hafez NH; Tahoun NS
J Egypt Natl Canc Inst; 2010 Jun; 22(2):123-34. PubMed ID: 21860469
[TBL] [Abstract][Full Text] [Related]
22. Myoepithelial cell staining patterns of papillary breast lesions: from intraductal papillomas to invasive papillary carcinomas.
Hill CB; Yeh IT
Am J Clin Pathol; 2005 Jan; 123(1):36-44. PubMed ID: 15762278
[TBL] [Abstract][Full Text] [Related]
23. Myoepithelial cell differentiation markers in ductal carcinoma in situ progression.
Russell TD; Jindal S; Agunbiade S; Gao D; Troxell M; Borges VF; Schedin P
Am J Pathol; 2015 Nov; 185(11):3076-89. PubMed ID: 26343330
[TBL] [Abstract][Full Text] [Related]
24. p63 expression in normal, hyperplastic and malignant breast tissues.
Wang X; Mori I; Tang W; Nakamura M; Nakamura Y; Sato M; Sakurai T; Kakudo K
Breast Cancer; 2002; 9(3):216-9. PubMed ID: 12185332
[TBL] [Abstract][Full Text] [Related]
25. p63 expression in benign and malignant breast lesions.
Stefanou D; Batistatou A; Nonni A; Arkoumani E; Agnantis NJ
Histol Histopathol; 2004 Apr; 19(2):465-71. PubMed ID: 15024707
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathologic observation of carcinomas arising in fibroepithelial neoplasms of the breast].
Yang G; Guo L; Jin H; Li J; Ding H
Zhonghua Bing Li Xue Za Zhi; 2014 Jul; 43(7):437-41. PubMed ID: 25327790
[TBL] [Abstract][Full Text] [Related]
27. Clinicopathological significance of 'atypical ductal proliferation' in core needle biopsy of the breast.
Abe E; Suzuki K; Hayashi N; Yang Y; Li CP; Uno M; Akiyama F; Yamauchi H; Nakamura S; Tsugawa K; Tsunoda H; Ohde S; Sasano H
Pathol Int; 2014 Feb; 64(2):58-66. PubMed ID: 24629173
[TBL] [Abstract][Full Text] [Related]
28. [The value of immunohistochemical expression of Ki-67 and CD34 in differentiating ductal carcinoma in situ from ductal carcinoma in situ-like invasive breast cancer].
Pan XY; Wu JK; Lang ZQ; Qu L; Jiang L
Zhonghua Bing Li Xue Za Zhi; 2022 Sep; 51(9):838-842. PubMed ID: 36097899
[No Abstract] [Full Text] [Related]
29. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray.
Reis-Filho JS; Simpson PT; Martins A; Preto A; Gärtner F; Schmitt FC
Virchows Arch; 2003 Aug; 443(2):122-32. PubMed ID: 12884041
[TBL] [Abstract][Full Text] [Related]
30. Comparative features of ductal carcinoma in situ and infiltrating ductal carcinoma of the breast on fine-needle aspiration biopsy.
Wang HH; Ducatman BS; Eick D
Am J Clin Pathol; 1989 Dec; 92(6):736-40. PubMed ID: 2556017
[TBL] [Abstract][Full Text] [Related]
31. Mean nuclear area and metallothionein expression in ductal breast tumors: correlation with estrogen receptor status.
El Sharkawy SL; Farrag AR
Appl Immunohistochem Mol Morphol; 2008 Mar; 16(2):108-12. PubMed ID: 18227734
[TBL] [Abstract][Full Text] [Related]
32. Morphologic, molecular and microenvironment factors associated with stromal invasion in breast ductal carcinoma in situ: Role of myoepithelial cells.
Aguiar FN; Cirqueira CS; Bacchi CE; Carvalho FM
Breast Dis; 2015; 35(4):249-52. PubMed ID: 26397772
[TBL] [Abstract][Full Text] [Related]
33. Comparison of the basal cell-specific markers, 34betaE12 and p63, in the diagnosis of prostate cancer.
Shah RB; Zhou M; LeBlanc M; Snyder M; Rubin MA
Am J Surg Pathol; 2002 Sep; 26(9):1161-8. PubMed ID: 12218572
[TBL] [Abstract][Full Text] [Related]
34. Cytologic diagnosis and grading of ductal carcinoma in situ.
McKee GT; Tildsley G; Hammond S
Cancer; 1999 Aug; 87(4):203-9. PubMed ID: 10455208
[TBL] [Abstract][Full Text] [Related]
35. Is a diagnosis of infiltrating versus in situ ductal carcinoma of the breast possible in fine-needle aspiration specimens?
Shin HJ; Sneige N
Cancer; 1998 Jun; 84(3):186-91. PubMed ID: 9678734
[TBL] [Abstract][Full Text] [Related]
36. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
[TBL] [Abstract][Full Text] [Related]
37. The cytopathology of ductal carcinoma in situ of the breast. A detailed analysis of fine needle aspiration cytology of 58 cases compared with 101 invasive ductal carcinomas.
Bonzanini M; Gilioli E; Brancato B; Cristofori A; Bricolo D; Natale N; Valentini A; Dalla Palma P
Cytopathology; 2001 Apr; 12(2):107-19. PubMed ID: 11284955
[TBL] [Abstract][Full Text] [Related]
38. p63 expression in breast cancer: a highly sensitive and specific marker of metaplastic carcinoma.
Koker MM; Kleer CG
Am J Surg Pathol; 2004 Nov; 28(11):1506-12. PubMed ID: 15489655
[TBL] [Abstract][Full Text] [Related]
39. Correlation of the ultrasound imaging of breast cancer and the expression of molecular biological indexes.
Xu J; Li F; Chang F
Pak J Pharm Sci; 2017 Jul; 30(4(Suppl.)):1425-1430. PubMed ID: 29043992
[TBL] [Abstract][Full Text] [Related]
40. Glucocorticoids promote transition of ductal carcinoma in situ to invasive ductal carcinoma by inducing myoepithelial cell apoptosis.
Zubeldia-Plazaola A; Recalde-Percaz L; Moragas N; Alcaraz M; Chen X; Mancino M; Fernández-Nogueira P; Prats de Puig M; Guzman F; Noguera-Castells A; López-Plana A; Enreig E; Carbó N; Almendro V; Gascón P; Bragado P; Fuster G
Breast Cancer Res; 2018 Jul; 20(1):65. PubMed ID: 29973218
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]